###begin article-title 0
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas/CD95</italic>
###xml 26 31 26 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 32 36 <span type="species:ncbi:10090">Mice</span>
Fas/CD95 Deficiency in ApcMin/+ Mice Increases Intestinal Tumor Burden
###end article-title 0
###begin p 1
Conceived and designed the experiments: HGA FC VAP. Performed the experiments: HGA. Analyzed the data: HGA MAS FC VAP. Wrote the paper: HGA FC VAP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Fas, a member of the tumor necrosis family, is responsible for initiating the apoptotic pathway when bound to its ligand, Fas-L. Defects in the Fas-mediated apoptotic pathway have been reported in colorectal cancer.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 42 47 42 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 181 186 181 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 177 194 177 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Apc<sup>Min/+</sup>/Fas<sup>lpr</sup>)</italic>
###xml 216 221 216 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 213 221 213 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 299 304 299 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 296 304 296 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 369 374 369 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 378 381 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 366 381 366 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 453 458 453 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 681 686 681 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 678 686 678 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 690 693 690 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 714 719 714 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 711 719 711 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
In the present study, a variant of the ApcMin/+ mouse, a model for the human condition, Familial Adenomatous Polyposis (FAP), was generated with an additional deficiency of Fas (ApcMin/+/Faslpr) by cross-breeding ApcMin/+ mice with Fas deficient (Faslpr) mice. One of the main limitations of the ApcMin/+ mouse model is that it only develops benign polyps. However, ApcMin/+/Faslpr mice presented with a dramatic increase in tumor burden relative to ApcMin/+ mice and invasive lesions at advanced ages. Proliferation and apoptosis markers revealed an increase in cellular proliferation, but negligible changes in apoptosis, while p53 increased at early ages. Fas-L was lower in ApcMin/+/Faslpr mice relative to ApcMin/+ cohorts, which resulted in enhanced inflammation.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 67 72 67 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 133 138 133 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
This study demonstrated that imposition of a Fas deletion in an ApcMin/+ background results in a more aggressive phenotype of the ApcMin/+ mouse model, with more rapid development of invasive intestinal tumors and a decrease in Fas-L levels.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 254 257 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Ashkenazi1">[1]</xref>
###xml 424 427 424 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Lee1">[2]</xref>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</italic>
###xml 463 466 463 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Itoh1">[3]</xref>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gld</italic>
###xml 487 490 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Suda1">[4]</xref>
###xml 876 879 876 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Danial1">[5]</xref>
Apoptosis is a regulated process that eliminates individual cells that are damaged or infected. There are several signals capable of triggering apoptosis, of which the activation of Fas/CD95/Apo-1 receptor (Fas) by Fas ligand (Fas-L) is the most studied [1]. Most information about the Fas pathway is based on the immune system, where Fas is highly expressed in activated T and B cells, thymocytes, and lung and liver cells [2]. Cloning of the Fas receptor (lpr) [3] and the Fas-L (gld) [4] genes led to studies involving their potential roles in the activation of the apoptotic pathway by death receptors. From these studies, a potential mechanism evolved in which interaction of Fas-L with Fas results in a conformational change of the receptor resulting in the assembly of the death-inducing signaling complex, which is able to recruit and cleave procaspase-8 (reviewed in [5]).
###end p 9
###begin p 10
###xml 236 239 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Yao1">[6]</xref>
###xml 553 556 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Mahidhara1">[7]</xref>
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Pitti1">[8]</xref>
###xml 778 781 778 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-OConnell1">[9]</xref>
###xml 984 988 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-OConnell2">[10]</xref>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Vaux1">[11]</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Yagita1">[12]</xref>
###xml 1089 1093 1089 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Restifo1">[13]</xref>
###xml 1120 1127 1120 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1136 1140 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Arai1">[14]</xref>
###xml 1142 1146 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Chappell1">[15]</xref>
###xml 1148 1152 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Kang1">[16]</xref>
###xml 1154 1158 1154 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Fingleton1">[17]</xref>
During colon cancer, regulation of the Fas system facilitates tumor development. Some studies have shown that resistance of colon carcinoma cells to apoptosis can be attributed to the elevated expression of Fas-associated phosphatase-1 [6], which inhibits Fas signaling by binding to the cytoplasmic tail of Fas. Another factor that may contribute to apoptosis resistance is incomplete Fas surface expression, with appropriate Fas mRNA levels but deficient posttranslational processing, attenuating its cell surface expression and remaining inactivated [7]. Amplification of a decoy receptor for Fas-L in lung and colon cancer has also been reported [8]. A number of investigations have proposed a "Fas counterattack", which is thought to be an anti-host tumor-derived response [9], where lymphocyte proliferation is compromised by tumor cells expressing Fas-L. This induces apoptosis in the lymphocytes, sparing tumor cells due to another mechanism, i.e., low Fas surface expression [10], [11], [12]. This notion however, remains controversial, and has been refuted by some investigators [13] and contradicted by other in vivo studies [14], [15], [16], [17].
###end p 10
###begin p 11
###xml 65 70 65 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Su1">[18]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Moser1">[19]</xref>
###xml 330 335 330 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 423 426 423 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Kinzler1">[20]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Matloff1">[21]</xref>
###xml 506 510 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Reya1">[22]</xref>
###xml 544 570 541 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Matrix metalloproteinase-7</italic>
###xml 570 574 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Castellone1">[23]</xref>
###xml 624 629 621 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 621 629 618 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 671 674 668 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 668 674 665 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 696 701 693 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 693 701 690 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 705 708 702 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 702 708 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 159 165 <span type="species:ncbi:9606">humans</span>
###xml 178 186 <span type="species:ncbi:9606">Patients</span>
###xml 336 341 <span type="species:ncbi:10090">mouse</span>
###xml 453 463 <span type="species:ncbi:111938">gatekeeper</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
The adenomatous polyposis coli multiple intestinal neoplasia (ApcMin/+) mouse model presents phenotypes reminiscent of Familial Adenomatous Polyposis (FAP) in humans [18], [19]. Patients with FAP develop multiple adenomas in the large intestine, which lead to the development of malignant adenocarcinomas. The relevance of the ApcMin/+ mouse model is that most colorectal cancers also show alterations in expression of the Apc gene [20], [21]. Apc is a gatekeeper that regulates the levels of beta-catenin [22], a transcription factor that has Matrix metalloproteinase-7[23] among its target genes. In the current study, ApcMin/+ mice were crossed with Fas deficient (Faslpr) mice to generate ApcMin/+/Faslpr mice in order to study the effect of a disrupted Fas-mediated apoptotic machinery on tumor development and progression. The results are summarized herein.
###end p 11
###begin title 12
Material and Methods
###end title 12
###begin title 13
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and Tissue Processing
###end title 13
###begin p 14
###xml 139 144 139 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 167 170 167 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 313 318 313 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 310 318 310 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 345 348 345 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 342 348 342 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 369 374 369 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 378 383 378 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr/+</sup>
###xml 366 383 366 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr/+</sup></italic>
###xml 426 431 426 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 435 438 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 423 438 423 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 453 458 453 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 466 471 466 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 475 478 475 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 463 478 463 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
The animal protocols used in this study were approved by the University of Notre Dame Institutional Animal Care and Use Committee. Male ApcMin/+ and Fas-deficient (Faslpr) mice (5 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME). All animals were fed a rodent chow diet. For these studies, ApcMin/+ mice were crossed with Faslpr mice to generate ApcMin/+/Faslpr/+ mice, which were then bred to generate ApcMin/+/Faslpr mice. Male ApcMin/+ and ApcMin/+/Faslpr mice (8, 12, 16, 20, and 30 weeks) in a C57BL/6 background, were used for all analyses. Tumor counting was performed under a dissecting microscope by investigators blinded to the genotype. Intestines were opened longitudinally, cleaned, Swiss-rolled, fixed with periodate-lysine-paraformaldehyde (PLP), and embedded in paraffin.
###end p 14
###begin title 15
Blood Analysis
###end title 15
###begin p 16
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Blood extracted intravenously from individual mice was treated with EDTA and an aliquot (50 microl) was applied to an automated CBC analyzer (Hemavet HV950FS, Drew Scientific, Oxford, CT, USA) in order to determine the number of leukocytes (lymphocytes, neutrophils, monocytes), erythrocytes (red blood cells, hemoglobin and hematocrit), and thrombocytes (platelets).
###end p 16
###begin title 17
Histochemistry and Immunohistochemistry
###end title 17
###begin p 18
###xml 183 189 <span type="species:ncbi:9986">rabbit</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 290 294 <span type="species:ncbi:9925">goat</span>
###xml 300 306 <span type="species:ncbi:9986">rabbit</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 409 414 <span type="species:ncbi:9606">human</span>
###xml 507 513 <span type="species:ncbi:9986">rabbit</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
###xml 559 564 <span type="species:ncbi:10090">mouse</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
###xml 659 665 <span type="species:ncbi:9986">rabbit</span>
###xml 671 676 <span type="species:ncbi:10090">mouse</span>
###xml 778 784 <span type="species:ncbi:9986">rabbit</span>
###xml 790 795 <span type="species:ncbi:10090">mouse</span>
###xml 900 905 <span type="species:ncbi:9823">swine</span>
###xml 911 917 <span type="species:ncbi:9986">rabbit</span>
###xml 1044 1047 <span type="species:ncbi:10116">rat</span>
###xml 1053 1058 <span type="species:ncbi:10090">mouse</span>
###xml 1145 1151 <span type="species:ncbi:9986">rabbit</span>
###xml 1157 1162 <span type="species:ncbi:10090">mouse</span>
###xml 1310 1316 <span type="species:ncbi:9986">rabbit</span>
###xml 1322 1325 <span type="species:ncbi:10116">rat</span>
###xml 1394 1398 <span type="species:ncbi:9925">goat</span>
###xml 1404 1410 <span type="species:ncbi:9986">rabbit</span>
Serial sections of paraffin-embedded tissue were cut for haematoxylin and eosin (H&E) staining and for immunostaining. Active caspase-3 and Fas-L were identified utilizing polyclonal rabbit-anti-human active caspase-3 and Fas-L antibodies (Abcam, Cambridge, MA), followed by HRP-conjugated goat-anti-rabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA). PCNA was identified utilizing a monoclonal mouse-anti-human PCNA antibody (BioGenex, San Ramon, CA) as the primary antibody, followed by HRP-conjugated rabbit-anti-mouse IgG (Santa Cruz Biotechnology). A mouse monoclonal-anti-mouse p53 antibody (Abcam) was used to detect p53, followed by HRP-conjugated rabbit-anti-mouse IgG (AbD Serotec, Oxford, UK). Total Akt and phosphorylated Akt were identified utilizing polyclonal rabbit-anti-mouse Akt and pAkt antibodies (Abcam and Cell Signaling, Danvers, MA, respectively), followed by biotinylated swine-anti-rabbit IgG (Dako, Carpinteria, CA) and HRP-conjugated streptavidin (BioGenex). CD45 and Mac-3 were identified utilizing a monoclonal rat-anti-mouse antibodies for CD45 and Mac-3 (Pharmingen, San Diego, CA), followed by a biotinylated rabbit-anti-mouse IgG (Dako, Carpinteria, CA) and HRP conjugated streptavidin (Jackson, West Grove, PA). Phosphorylated Foxo3a was identified utilizing a polyclonal rabbit-anti-rat Foxo3a (phosphor S253) antibody (Abcam), followed by HRP-conjugated goat-anti-rabbit IgG (Santa Cruz Biotechnology). All stains were then developed in 3, 3'-diaminobenzidine (DAB) and a haematoxylin QS counterstain was applied (Vector Laboratories, Burlington, CA).
###end p 18
###begin title 19
Stain Quantification and Statistical Analysis
###end title 19
###begin p 20
Immunohistochemical stains were quantified using Spectrum Plus (Version 9.0.748.1518) and ImageScope software (Aperio Technologies, Vista, CA). Slides were scanned and loaded into an electronic database at 20X by ScanScope CS (Aperio Technologies). For each stain, algorithms were developed to analyze either the percent positive stained area per tumor area (Fas-L, Akt and pAkt) or the number of positive cells per tumor area (PCNA, caspase-3, p53, CD45, Mac-3 and p-Foxo3a).
###end p 20
###begin p 21
Scanned slides were viewed in ImageScope where regions were drawn around each tumor and analyzed with Spectrum software, using algorithms designed for each stain. Stains using percent positive area were analyzed using color deconvolution algorithms. Stains requiring the number of positive cells per tumor area were analyzed using algorithms that separate color by optical density and also separate cells by outer membrane size and roundness. Cells that fit within the parameters set for desired cell size and shape and stain were counted, as was the area of each tumor region. The average number of cells per tumor area was then determined.
###end p 21
###begin title 22
Statistical Analysis
###end title 22
###begin p 23
For survival studies, the data were analyzed using the Kaplan-Meier treatment and the comparison of survival between both genotypes was performed using the log-rank test with Prism 4 software (GraphPad Software, La Jolla, CA). The Student's t-test was used for comparison of single pairs.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 19 24 19 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 16 24 16 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 25 29 <span type="species:ncbi:10090">Mice</span>
Fas Deletion in ApcMin/+ Mice Increases the Size and Number of Intestinal Adenomas
###end title 25
###begin p 26
###xml 260 265 260 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 257 272 257 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 348 353 348 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 345 353 345 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 427 432 427 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 436 439 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 424 439 424 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 501 506 501 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 498 506 498 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 677 682 677 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 686 689 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 674 689 674 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 706 711 706 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 715 718 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 703 718 703 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 801 808 801 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g001">Fig. 1A</xref>
###xml 869 874 869 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 878 881 878 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 866 881 866 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 960 965 960 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 957 965 957 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 979 982 979 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 976 982 976 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 1061 1066 1061 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1058 1066 1058 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1145 1152 1145 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g001">Fig. 1B</xref>
###xml 1193 1198 1193 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1202 1205 1202 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1190 1205 1190 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1259 1264 1259 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1256 1264 1256 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1290 1295 1290 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1287 1295 1287 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1382 1387 1382 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1391 1394 1391 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1379 1394 1379 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1574 1579 1574 1579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1571 1579 1571 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1615 1620 1615 1620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1624 1627 1624 1627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1612 1627 1612 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1651 1656 1651 1656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1660 1663 1660 1663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1648 1663 1648 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1726 1731 1726 1731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1723 1731 1723 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1738 1745 1738 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g001">Fig. 1C</xref>
###xml 1859 1864 1859 1864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1868 1871 1868 1871 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1856 1871 1856 1871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1878 1879 1878 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1901 1906 1901 1906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1898 1906 1898 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1912 1916 1912 1916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n&#8202;=&#8202;</italic>
###xml 1948 1953 1948 1953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1957 1960 1957 1960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1945 1960 1945 1960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 2094 2097 2094 2097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 2091 2097 2091 2097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 2103 2107 2103 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Wofsy1">[24]</xref>
###xml 2132 2137 2132 2137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 2129 2137 2129 2137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 2147 2152 2147 2152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 2156 2159 2156 2159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 2144 2159 2144 2159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 2225 2231 2225 2231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g002">Fig. 2</xref>
###xml 2321 2326 2321 2326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 2318 2326 2318 2326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 2423 2427 2423 2427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Boivin1">[25]</xref>
###xml 2490 2497 2490 2497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009070-t001">Table 1</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 929 934 <span type="species:ncbi:10090">mouse</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1066 1070 <span type="species:ncbi:10090">mice</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
###xml 1265 1269 <span type="species:ncbi:10090">mice</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
###xml 1395 1399 <span type="species:ncbi:10090">mice</span>
###xml 1580 1584 <span type="species:ncbi:10090">mice</span>
###xml 1628 1632 <span type="species:ncbi:10090">mice</span>
###xml 1664 1668 <span type="species:ncbi:10090">mice</span>
###xml 1732 1736 <span type="species:ncbi:10090">mice</span>
###xml 1872 1876 <span type="species:ncbi:10090">mice</span>
###xml 1906 1910 <span type="species:ncbi:10090">mice</span>
###xml 1961 1965 <span type="species:ncbi:10090">mice</span>
###xml 2098 2102 <span type="species:ncbi:10090">mice</span>
###xml 2138 2142 <span type="species:ncbi:10090">mice</span>
###xml 2160 2164 <span type="species:ncbi:10090">mice</span>
###xml 2327 2331 <span type="species:ncbi:10090">mice</span>
Based on preliminary transcriptional profiling results of human colon cancer samples, where a strong downregulation of a FAS-related receptor was observed (data not shown), along with published reports of compromised Fas-mediated apoptosis in colon cancer, ApcMin/+/Faslpr mice were generated to determine the effects of a Fas deficiency in the ApcMin/+ mouse model. Intestines harvested at various timepoints revealed that ApcMin/+/Faslpr mice developed dramatically more intestinal adenomas than ApcMin/+mice, increasing rapidly with time (p<0.00001 at 8 weeks, p = 0.0072 at 12 weeks, p = 0.0012 at 16 weeks, p = 0.00019 at 20 weeks and p<0.00001 at 30 wks, n = 4-10 for ApcMin/+/Faslpr and 5-21 for ApcMin/+/Faslpr), and reaching a plateau of slightly more than 70 adenomas after 16 weeks of age (Fig. 1A). The largest difference was observed at 20 weeks, where ApcMin/+/Faslpr mice had on average 87 intestinal adenomas per mouse compared to 13 in the ApcMin/+ mice. The Faslpr mice, alone, did not generate any intestinal polyps. For most time points, ApcMin/+mice had slightly larger adenomas, reaching significance at 16 weeks (p<0.05) (Fig. 1B). At 30 weeks however, adenomas from ApcMin/+/Faslpr mice were significantly larger than adenomas from ApcMin/+ mice (p<0.01). Unlike ApcMin/+ mice, where the location of adenomas is almost exclusively in the small intestine, ApcMin/+/Faslpr mice after 16 weeks presented with large adenomas in the large intestine, additional to the ones located at the small intestine. Although there was significant tumor burden in ApcMin/+ mice, it was much lower than in ApcMin/+/Faslpr mice. Additionally, ApcMin/+/Faslpr mice had a significantly reduced survival rate relative to ApcMin/+ mice (Fig. 1C). The survival curves were compared using a log-rank test showing a significantly lower survival (p<0.001) in ApcMin/+/Faslpr mice (n = 35) compared to ApcMin/+mice (n = 89). The percent survival of ApcMin/+/Faslpr mice strongly decreased between 25 and 30 weeks and reached 44% at 30 weeks. This is about 12 weeks earlier than that observed in Faslpr mice [24]. Furthermore, unlike ApcMin/+ mice, ApcMin/+/Faslpr mice presented with invasive lesions in all animals at 30 weeks (Fig. 2). The invasive lesions are not to be confused with herniation, a common occurrence in ApcMin/+ mice. All specimens were analyzed by a veterinary pathologist utilizing standardized guidelines [25]. The percentage of invasive lesions ranged from 3.0 to 15.4% (Table 1). However, metastasis to other organs was not detected.
###end p 26
###begin title 27
Tumor burden and survival.
###end title 27
###begin p 28
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 30 31 30 31 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 50 51 50 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 73 78 73 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 86 91 86 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 83 98 83 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 135 136 135 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
(A) Intestinal tumor number, (B) tumor size, and (C) survival rate of ApcMin/+ and ApcMin/+/Faslpr mice. Error bars in panels (A) and (B) represent standard error of the mean.
###end p 28
###begin title 29
Invasive lesions.
###end title 29
###begin p 30
###xml 48 53 48 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 45 60 45 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 331 336 331 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 328 336 328 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
H&E stains of intestinal adenoma sections of ApcMin/+/Faslpr mice at 30 weeks. The panel on the top represents an entire polyp with evidence of an invasive lesion, further magnified in the lower panel. Invasive lesions were analyzed by a veterinary pathologist and were not identified as areas of herniation, which is common in ApcMin/+ mice.
###end p 30
###begin title 31
###xml 45 50 45 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 42 57 42 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Percentage of invasive lesions in 30 week ApcMin/+/Faslpr mice.
###end title 31
###begin title 32
###xml 17 22 17 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 14 29 14 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 30 34 <span type="species:ncbi:10090">Mice</span>
Adenomas from ApcMin/+/Faslpr Mice Show Increased Proliferation
###end title 32
###begin p 33
###xml 43 48 43 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 40 55 40 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 205 211 205 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g003">Fig. 3</xref>
###xml 377 382 377 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 386 389 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 374 389 374 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 453 458 453 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 592 597 592 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 601 604 601 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 589 604 589 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 629 634 629 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 626 634 626 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 662 668 662 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g003">Fig. 3</xref>
###xml 761 766 761 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 770 773 770 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 758 773 758 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 882 887 882 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 879 887 879 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1017 1022 1017 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1026 1029 1026 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1014 1029 1014 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1050 1055 1050 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1047 1055 1047 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1061 1067 1061 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g004">Fig. 4</xref>
###xml 1195 1200 1195 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1204 1207 1204 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1192 1207 1192 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1228 1233 1228 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1225 1233 1225 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1265 1270 1265 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1274 1277 1274 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1262 1277 1262 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1302 1307 1302 1307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1299 1307 1299 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 887 891 <span type="species:ncbi:10090">mice</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
###xml 1208 1212 <span type="species:ncbi:10090">mice</span>
###xml 1234 1238 <span type="species:ncbi:10090">mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
To determine if increased polyps in the ApcMin/+/Faslpr mice were due to an increase in cellular proliferation and/or a decrease in apoptosis, cells positive for proliferating cell nuclear antigen (PCNA) (Fig. 3) and caspase-3 (data not shown) were determined by immunohistochemistry. Several (18-205) polyps from at least 4 mice were used for each time point and genotype. ApcMin/+/Faslpr mice had significantly more PCNA+ cells per tumor area than ApcMin/+ mice at most time points (p = 0.0014 at 8 weeks, p = 0.0038 at 16 weeks, p<0.0001 at 20 weeks and 30 weeks, n = 24-205 tumors for ApcMin/+/Faslpr and 18-58 tumors for ApcMin/+ in 4-5 mice per genotype) (Fig. 3). Apoptosis activity was determined by measuring cleaved caspase-3 levels. Surprisingly, ApcMin/+/Faslpr did not show a significant change in caspase-3+ cells per tumor area at any time point, when compared to ApcMin/+mice. As another marker of apoptosis, p53 was also measured by immunohistochemistry. An increase in p53 levels was observed in ApcMin/+/Faslpr mice compared to ApcMin/+mice (Fig. 4). The p53 increase was observed at early time points; 8 weeks (p = 0.0009), 12weeks (p = 0.012), and 16 weeks (p<0.0001) in ApcMin/+/Faslpr mice compared to ApcMin/+ mice (n = 26-177 tumors for ApcMin/+/Faslpr and 18-78 tumors for ApcMin/+ in 4-5 mice per genotype). After 20 weeks, both genotypes had similar levels of p53.
###end p 33
###begin title 34
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/Fas<sup>lpr</sup></italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Immunohistochemistry for PCNA in adenomas from ApcMin/+ and ApcMin/+/Faslpr mice.
###end title 34
###begin p 35
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 35 40 35 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 32 47 32 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 54 59 54 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
(A) PCNA immunostains comparing ApcMin/+/Faslpr to ApcMin/+ mice at 8 and 20 weeks. (B) Quantitation of PCNA positive cells per tumor area at five different time points. Error bars represent standard error of the mean.
###end p 35
###begin title 36
###xml 49 53 49 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 66 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 59 66 59 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Apc<sup>Min/</sup></italic></bold>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 74 71 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/Fas<sup>lpr</sup></italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Immunohistochemistry for p53 in adenomas from ApcMin/+ and ApcMin/+/Faslpr mice.
###end title 36
###begin p 37
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 52 57 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 49 64 49 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 77 82 77 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
(A) Immunostains for the apoptosis marker p53 in ApcMin/+/Faslpr mice and ApcMin/+ mice at 8 and 20 weeks. (B) Quantitation of p53 positive cells per tumor area at five different time points. Error bars represent standard error of the mean.
###end p 37
###begin title 38
###xml 25 30 25 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 31 35 <span type="species:ncbi:10090">Mice</span>
Fas-L Is Decreased in ApcMin/+ Mice Lacking Fas
###end title 38
###begin p 39
###xml 103 108 103 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Fingleton1">[17]</xref>
###xml 285 290 285 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 282 290 282 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 298 303 298 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 295 310 295 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 317 323 317 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g005">Fig. 5</xref>
###xml 347 352 347 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 344 359 344 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 417 422 417 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 414 422 414 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 565 570 565 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 574 577 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 562 577 562 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 602 607 602 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 599 607 599 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 615 619 <span type="species:ncbi:10090">mice</span>
Another study has reported an increase in intestinal tumorigenesis once functional Fas-L is lost in ApcMin/+ mice [17]. To determine if, in our Fas-deficient model, the levels of Fas-L within the adenomas were altered, immunostains of Fas-L were performed on intestinal sections of ApcMin/+ and ApcMin/+/Faslpr mice (Fig. 5). Adenomas from the ApcMin/+/Faslpr mice had significantly less Fas-L per tumor area than ApcMin/+mice. This observation was consistent for all time points (p = 0.039 at 8 weeks, p<0.0001 at 12, 16, 20 and 30 weeks, n = 28-198 tumors for ApcMin/+/Faslpr and 17-93 tumors for ApcMin/+ in 4-5 mice per genotype).
###end p 39
###begin title 40
###xml 51 55 51 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 61 68 61 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Apc<sup>Min/</sup></italic></bold>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/Fas<sup>lpr</sup></italic>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Immunohistochemistry for Fas-L in adenomas from ApcMin/+ and ApcMin/+/Faslpr mice.
###end title 40
###begin p 41
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 40 45 40 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 37 52 37 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 60 65 60 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 91 92 91 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
(A) Immunostains for Fas-L comparing ApcMin/+/Faslpr and ApcMin/+ mice at 8 and 20 weeks. (B) Quantitation of Fas-L immunostains. Error bars represent standard error of the mean.
###end p 41
###begin title 42
###xml 67 72 67 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 76 79 76 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 64 79 64 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 87 92 87 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 93 97 <span type="species:ncbi:10090">Mice</span>
Akt, Foxo3a, and Inflammatory Markers in Intestinal Tumors from ApcMin/+/Faslpr and ApcMin/+ Mice
###end title 42
###begin p 43
###xml 206 211 206 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 203 218 203 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 226 231 226 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 223 231 223 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 238 245 238 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g006">Fig. 6A</xref>
###xml 318 323 318 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 315 323 315 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 348 349 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 380 385 378 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 389 392 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 377 392 375 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 418 419 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 452 459 448 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g006">Fig. 6B</xref>
###xml 557 562 553 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 554 562 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 588 589 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 620 625 614 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 629 632 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 617 632 611 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 659 660 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
Fas-L, aside from triggering Fas dependent apoptosis, is considered to be an inducer of inflammation. To analyze inflammation within tumors, stains for CD45 and Mac-3 were performed on the intestines of ApcMin/+/Faslpr and ApcMin/+ mice (Fig. 6A). At 30 weeks, there were fewer positive cells for CD45 in tumors of ApcMin/+ mice (617+/-99 +cells/mm2, n = 17 in 4 mice) than in ApcMin/+/Faslpr mice (2006+/-86 +cells/mm2, n = 133 in 5 mice) (p<0.0001) (Fig. 6B). Mac-3, an antigen present on macrophages, had the same trend with lower levels in tumors of ApcMin/+ mice (623+/-166 +cells/mm2, n = 21 in 4 mice) than in ApcMin/+/Faslpr mice (5804+/-175 +cells/mm2, n = 151 in 5 mice) (p<0.0001).
###end p 43
###begin title 44
###xml 31 35 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc</italic>
###xml 44 49 44 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/Fas<sup>lpr</sup></italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Inflammation in adenomas of ApcMin/+ and ApcMin/+/Faslpr mice.
###end title 44
###begin p 45
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 77 82 77 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 90 95 90 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 87 102 87 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 122 123 122 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
(A) Immunostains for Mac-3, CD45, p-Foxo3a, Akt and pAkt in adenomas from ApcMin/+ and ApcMin/+/Faslpr mice at 30 weeks. (B) Quantitation of Mac-3, CD45, p-Foxo3a, Akt, and pAkt immunostains. Error bars represent standard error of the mean.
###end p 45
###begin p 46
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g006">Fig. 6A</xref>
###xml 203 208 203 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 200 215 200 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 408 413 400 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 405 413 397 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 431 438 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g006">Fig. 6B</xref>
###xml 633 637 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Brunet1">[26]</xref>
###xml 639 643 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Suhara1">[27]</xref>
###xml 754 759 746 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 763 766 755 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 751 766 743 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 793 794 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 844 849 834 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 841 849 831 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 876 877 864 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 910 919 898 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g006">Fig. 6A,B</xref>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
In addition to PCNA, cell survival was further analyzed by staining for total Akt and its activated phosphorylated form (p-Akt) (Fig. 6A). The stains revealed a predictable trend in which tumors from ApcMin/+/Faslpr mice showed higher levels of Akt (63.8%+/-7.6 n = 199 in 5 mice, versus 40.6%+/-4.1, n = 21 in 4 mice) and pAkt (53.0%+/-10.8, n = 186 in 5 mice, versus 13.7%+/-2.0, n = 28 in 5 mice) than ApcMin/+ mice (p<0.0001) (Fig. 6B). Akt is reported to decrease expression of Fas-L by phosphorylating and, therefore, inhibiting Foxo3a, a member of the forkhead family of transcription factors responsible for Fas-L expression [26], [27]. In accordance with those reports, levels of phosphorylated Foxo3a (p-Foxo3a) were higher in the tumors of ApcMin/+/Faslpr mice (7038+/-230 +cells/mm2, n = 139 in 4 mice) compared to the tumors in ApcMin/+ mice (5523+/-398 +cells/mm2, n = 20 in 3 mice) (p = 0.017) (Fig. 6A,B).
###end p 46
###begin title 47
Hematology Profile
###end title 47
###begin p 48
Prior to perfusion, blood was collected from all animals for hematological profiling. Measurements of leukocyte (neutrophils, lymphocytes, and monocytes) levels revealed that the averages remained within the normal ranges (data not shown).
###end p 48
###begin p 49
###xml 3 8 3 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 143 148 143 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fas<sup>lpr</sup></italic>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
ApcMin/+/Faslpr mice, at most time points, were anemic as determined by red blood cell counts, hemoglobin, and percent hematocrit. However, ApcMin/+ mice, as well as Faslpr mice were also anemic. Platelets, in all cases, were within normal ranges (data not shown).
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 32 37 32 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 292 297 292 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 301 304 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 289 304 289 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 394 399 394 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 403 406 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 391 406 391 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
This study demonstrated that ApcMin/+ mice develop more intestinal adenomas when Fas is absent. An increase in proliferation (measured by PCNA) was evident, especially at later time points where an increase in Akt and pAkt was also observed. Additionally, there was a decrease in Fas-L in ApcMin/+/Faslpr mice. A significant increase in inflammation and Mac-3 was also observed in tumors of ApcMin/+/Faslpr mice.
###end p 51
###begin p 52
###xml 94 99 94 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 285 290 285 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 282 297 282 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Bedi1">[28]</xref>
###xml 784 789 784 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 793 796 793 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 781 796 781 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 817 822 817 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 814 822 814 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 904 909 904 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 901 909 901 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 929 933 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Fingleton1">[17]</xref>
###xml 1012 1017 1012 1017 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1021 1024 1021 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1009 1024 1009 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1045 1050 1045 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1042 1050 1042 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1181 1186 1181 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1190 1193 1190 1193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1178 1193 1178 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1214 1219 1214 1219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1211 1219 1211 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Burgering1">[29]</xref>
###xml 1296 1300 1296 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Franke1">[30]</xref>
###xml 1466 1470 1466 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Altomare1">[31]</xref>
###xml 1625 1629 1625 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Mayo1">[32]</xref>
###xml 1631 1635 1631 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Zhou1">[33]</xref>
###xml 1804 1808 1804 1808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Fuchs1">[34]</xref>
###xml 1810 1814 1810 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-OConnor1">[35]</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1194 1198 <span type="species:ncbi:10090">mice</span>
###xml 1219 1223 <span type="species:ncbi:10090">mice</span>
In the present study it was observed that at all time points (8, 12, 16, 20 and 30 weeks), ApcMin/+ mice developed substantially more intestinal adenomas when Fas was eliminated. These adenomas also proved to be more aggressive. Incidences of intestinal prolapse were common in the ApcMin/+/Faslpr mice, especially at the later time points. Overall, the poor health of these animals was evidenced by their diminished survival rate as they approached 30 weeks of age. These findings were not surprising and were in accord with expectations from disruption of the apoptotic pathway [28]. However, the levels of the apoptotic markers, activated caspase-3 and p53, were unexpected. There were no differences in activated caspase-3 levels, but an increase in p53 levels was observed in ApcMin/+/Faslpr mice compared to ApcMin/+ mice. Changes in cleaved caspase-3 were also absent in previous studies using ApcMin/+ mice lacking Fas-L [17]. On the other hand, p53, also an apoptotic marker, was higher in tumors of ApcMin/+/Faslpr mice compared to ApcMin/+mice at early time points. However, this difference was attenuated at 30 weeks, when Akt and pAkt were observed to be higher in ApcMin/+/Faslpr mice compared to ApcMin/+mice. Akt is a protein kinase activated by a variety of growth factors [29], [30] that in turn triggers activation of several cancer-relevant downstream effector molecules, resulting in an environment that promotes proliferation and cell survival [31]. It has previously been reported that Akt is capable of downregulating p53 through phosphorylation of Mdm2 that results in a translocation to the nucleus [32], [33]. The increase of p53 might also be a compensatory mechanism for a lack of Fas pathway. The interdependence between Fas and p53 pathways has been demonstrated by others [34], [35].
###end p 52
###begin p 53
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Brunet1">[26]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Suhara1">[27]</xref>
###xml 235 240 235 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 232 247 232 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 329 334 329 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 326 334 326 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 382 387 382 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 379 387 379 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Arai1">[14]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Seino1">[36]</xref>
###xml 729 734 729 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 726 734 726 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Fingleton1">[17]</xref>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Hahne1">[37]</xref>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Mann1">[38]</xref>
###xml 1283 1288 1283 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1292 1295 1292 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1280 1295 1280 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1346 1351 1346 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1343 1351 1343 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1486 1491 1486 1491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1495 1498 1495 1498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 1483 1498 1483 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 1595 1601 1595 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009070-g007">Fig. 7</xref>
###xml 1688 1692 1688 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Hohlbaum1">[39]</xref>
###xml 1745 1749 1745 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Powell1">[40]</xref>
###xml 1758 1763 1758 1763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 1755 1763 1755 1763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 1839 1843 1839 1843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-GuillenAhlers1">[41]</xref>
###xml 1845 1849 1845 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Kita1">[42]</xref>
###xml 2350 2355 2350 2355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 2359 2362 2359 2362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 2347 2362 2347 2362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 388 393 <span type="species:ncbi:10090">mouse</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
###xml 885 891 <span type="species:ncbi:10090">murine</span>
###xml 1296 1300 <span type="species:ncbi:10090">mice</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1499 1503 <span type="species:ncbi:10090">mice</span>
###xml 1764 1769 <span type="species:ncbi:10090">mouse</span>
###xml 2363 2367 <span type="species:ncbi:10090">mice</span>
In accordance with reports indicating that Akt regulation in Fas-L expression is due to phosphorylation and, therefore, cytoplasmic retention of the forkhead transcription factor FKHRL1/Foxo3a [26], [27], intestinal adenomas of the ApcMin/+/Faslpr mice at later time points presented with fewer Fas-L than tumors found in the ApcMin/+mice. This observation indicates that in the ApcMin/+ mouse model, a Fas deficiency does not compromise tumor growth. On the contrary, by disrupting the Fas machinery, these tumors developed faster, and in greater numbers. These results are consistent with previous reports highlighting the anti-tumor effects of Fas-L [14], [36], as well as with recent findings of increased tumor burden in ApcMin/+ mice deficient for Fas-L [17]. However, there are a number of studies that report opposite findings where Fas-L confers more rapid tumor formation in murine melanoma cells [37]. Higher Fas-L expression has also been reported in liver metastasis of colon cancer compared to the primary tumor [38]. Those findings might represent a compensatory mechanism for a disrupted Fas-mediated apoptotic pathway. Despite the general assumption that high levels of Fas-L would induce inflammation within the tumors, in the present study it was observed that ApcMin/+/Faslpr mice, which had far lower levels of Fas-L than ApcMin/+ mice, showed an increase in inflammation at 30 weeks of age. The mechanism behind the increased level of inflammation in tumors of ApcMin/+/Faslpr mice is likely related to a balance between membrane Fas-L (mFas-L) and soluble Fas-L (sFas-L) (Fig. 7). mFas-L is a well known inducer of inflammation while sFas-L has the opposite effect [39]. Mmp7 is capable of cleaving mFas-L to yield sFas-L [40]. The ApcMin/+ mouse model and colon cancer in general show elevated levels of matrilysin [41], [42]. Therefore, it is not unlikely to assume that in this context the balance between mFas-L and sFas-L would favor its soluble form and therefore a direct correlation between Fas-L and inflammation levels would be expected, as was observed in the present study. Fas-L expression is regulated by Foxo3a, a member of the forkhead family of transcription factors. Akt has been reported to decrease Fas-L expression by phosphorylation and therefore inactivation of Foxo3a. In accord with this mechanism, ApcMin/+/Faslpr mice showed higher levels of Akt, p-Akt, and p-Foxo3a, and lower levels of Fas-L.
###end p 53
###begin title 54
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/</sup>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/</sup></italic>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Proposed model for the increase in tumor burden in absence of Fas/CD95 in ApcMin/+ mice.
###end title 54
###begin p 55
p-Akt inactivates Foxo3a by phosphorylation and p-Foxo3a is not able to translocate to the nucleus. Foxo3a is involved in the transcription of Fas-L. Fas-L forms a homotrimer transmembrane complex with a cleavage site (black circles), that is recognized by Mmp7. Mmp7 cleavage of mFas-L yields sFas-L (grey rectangles). The membrane and soluble forms of Fas-L have opposite effects on inflammation.
###end p 55
###begin p 56
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Coussens1">[43]</xref>
###xml 305 310 305 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 314 317 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 302 317 302 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Green1">[44]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Pollard1">[45]</xref>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
A relationship between inflammation and cancer has been identified in a number of studies, and it is widely accepted that inflammation creates conditions that promote tumor development (reviewed in [43]). Furthermore, Mac-3, an antigen present on macrophages, was present at higher levels in tumors of ApcMin/+/Faslpr mice and their presence within tumors promoted tumor growth, invasion, and metastasis [44], [45].
###end p 56
###begin p 57
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Fingleton1">[17]</xref>
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 168 173 168 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 272 277 272 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 269 277 269 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 516 522 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 712 718 700 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 852 857 840 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 849 857 837 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 977 982 965 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 986 989 974 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 974 989 962 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
The results of the present study correlate to those of Fingleton et al.[17] with differences that are worthy of further consideration. Fingleton et al. used 17 week ApcMin/+ mice lacking Fas-L instead of its receptor, Fas. Both studies detected high levels of Fas-L in ApcMin/+ mice. While deficiencies of either Fas or FasL resulted in an increase in tumor burden, in the current study, the increases in tumor number ranged from approximately300%, at early time points, to over 500%, at 16 weeks, whereas Fingleton et al. observed an increase nearly 100% at 17 weeks. These differences in tumor burden are most likely associated with difference in the inflammatory response observed in these studies. Fingleton et al. did not observe any significant changes in macrophage or lymphocyte infiltration, but did see a 3-fold decrease in neutrophils in ApcMin/+ mice lacking Fas-L. In contrast, the current study demonstrated an obvious increase in the inflammatory response in ApcMin/+/Faslpr mice. This supports the premise that the role played by in inflammation is more relevant in tumor development than it is in tumor evasion of the immune system. The current study, however, suggests that in intestinal adenomas, the balance between mFas-L and sFas-L levels, resulting from Mmp7 proteolysis, may regulate the pro- or anti-inflammatory properties of Fas-L.
###end p 57
###begin p 58
###xml 48 53 48 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 45 60 45 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 122 127 122 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 119 127 119 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 188 193 188 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lpr</sup>
###xml 185 200 185 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup>/Fas<sup>lpr</sup></italic>
###xml 261 266 261 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 258 266 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Thant1">[46]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Bjornsti1">[47]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009070-Luo1">[48]</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 267 272 <span type="species:ncbi:10090">mouse</span>
Among the main objectives for generating the ApcMin/+/Faslpr mice was to determine if a more aggressive variant of the ApcMin/+ mouse model would evolve. At 30 weeks of age, all of the ApcMin/+/Faslpr mice had invasive lesions, which was not observed in the ApcMin/+ mouse model. It is likely that invasive lesions arise, at least in part, as a result of an increase in Akt and its active form, since this kinase has been shown to be involved in tumor invasion and metastasis [46], [47], [48].
###end p 58
###begin p 59
###xml 76 81 76 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Min/+</sup>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apc<sup>Min/+</sup></italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
In summary, this study demonstrated that an additional Fas deficiency in ApcMin/+ mice causes a dramatic increase in the number of intestinal tumors. The increase in the incidence of adenoma development and the invasiveness of these adenomas, paralleling a decrease in Fas-L in these mice, does not support the Fas counterattack notion in this model. The increase in Mac-3 and CD45 suggests a tumor permissive environment caused by a Fas-L modulated inflammation.
###end p 59
###begin p 60
The authors thank Ms. Heather Tipton for assistance with imaging and Sarah Chapman and Mayra Sandoval-Cooper for assistance with histology.
###end p 60
###begin title 61
References
###end title 61
###begin article-title 62
Apoptosis control by death and decoy receptors.
###end article-title 62
###begin article-title 63
Differential regulation and function of Fas expression on glial cells.
###end article-title 63
###begin article-title 64
###xml 40 45 <span type="species:ncbi:9606">human</span>
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.
###end article-title 64
###begin article-title 65
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.
###end article-title 65
###begin article-title 66
Cell death: critical control points.
###end article-title 66
###begin article-title 67
###xml 23 28 <span type="species:ncbi:9606">human</span>
Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
###end article-title 67
###begin article-title 68
Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma.
###end article-title 68
###begin article-title 69
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
###end article-title 69
###begin article-title 70
###xml 138 143 <span type="species:ncbi:9606">human</span>
Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
###end article-title 70
###begin article-title 71
Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.
###end article-title 71
###begin article-title 72
Immunology. Ways around rejection.
###end article-title 72
###begin article-title 73
CD95 ligand in graft rejection.
###end article-title 73
###begin article-title 74
Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.
###end article-title 74
###begin article-title 75
Gene transfer of Fas ligand induces tumor regression in vivo.
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human melanoma cells do not express Fas (Apo-1/CD95) ligand.
###end article-title 76
###begin article-title 77
Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection.
###end article-title 77
###begin article-title 78
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
###end article-title 78
###begin article-title 79
###xml 58 64 <span type="species:ncbi:10090">murine</span>
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.
###end article-title 79
###begin article-title 80
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.
###end article-title 80
###begin article-title 81
Lessons from hereditary colorectal cancer.
###end article-title 81
###begin article-title 82
A clinician's guide to hereditary colon cancer.
###end article-title 82
###begin article-title 83
Wnt signalling in stem cells and cancer.
###end article-title 83
###begin article-title 84
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.
###end article-title 84
###begin article-title 85
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.
###end article-title 85
###begin article-title 86
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Pathology of mouse models of intestinal cancer: consensus report and recommendations.
###end article-title 86
###begin article-title 87
Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor.
###end article-title 87
###begin article-title 88
Suppression of Akt signaling induces Fas ligand expression: Involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation.
###end article-title 88
###begin article-title 89
Inhibition of apoptosis during development of colorectal cancer.
###end article-title 89
###begin article-title 90
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.
###end article-title 90
###begin article-title 91
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.
###end article-title 91
###begin article-title 92
###xml 46 51 <span type="species:ncbi:9606">human</span>
Perturbations of the AKT signaling pathway in human cancer.
###end article-title 92
###begin article-title 93
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
###end article-title 93
###begin article-title 94
Novel targets of Akt, p21(Cipl/WAF1), and MDM2.
###end article-title 94
###begin article-title 95
p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32{beta}.
###end article-title 95
###begin article-title 96
CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types.
###end article-title 96
###begin article-title 97
Antitumor effect of locally produced CD95 ligand.
###end article-title 97
###begin article-title 98
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
###end article-title 98
###begin article-title 99
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas.
###end article-title 99
###begin article-title 100
Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival.
###end article-title 100
###begin article-title 101
The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.
###end article-title 101
###begin article-title 102
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.
###end article-title 102
###begin article-title 103
Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.
###end article-title 103
###begin article-title 104
Inflammation and cancer.
###end article-title 104
###begin article-title 105
Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization.
###end article-title 105
###begin article-title 106
Tumour-educated macrophages promote tumour progression and metastasis.
###end article-title 106
###begin article-title 107
Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.
###end article-title 107
###begin article-title 108
Lost in translation: dysregulation of cap-dependent translation and cancer.
###end article-title 108
###begin article-title 109
###xml 34 39 <span type="species:ncbi:9606">human</span>
Targeting the PI3K-Akt pathway in human cancer: rationale and promise.
###end article-title 109
###begin p 110
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 110
###begin p 111
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH (NHLBI) grant HL 73750 (FJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 111

